Publication details

Use of pemetrexed as first line treatment of advanced non-small cell lung cancer: The Czech Republic experience with the treatment of 237 patients (pts)

Authors

SKŘIČKOVÁ Jana BORTLÍČEK Zbyněk HEJDUK Karel PEŠEK M. KOLEK V. KOUBKOVÁ L. TOMÍŠKOVÁ Marcela ROUBEC J. ZATLOUKAL P. SALAJKA F.

Year of publication 2012
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation
Attached files
Description The Czech Republic has had an opportunity to use pemetrexed for 1st line treatment of advanced NSCLC from the year 2008. The purpose of this trial was to evaluate the activity and feasibility of pemetrexed in 1st line treatment NSCLC patients.

You are running an old browser version. We recommend updating your browser to its latest version.

More info